Azurin-p28
N/A
Report date: 2022/07/19 16:22:54
Base Information
Drug NameAzurin-p28
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[9]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois At ChicagoCdg Therapeutics
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesDr. Tapas K. Das GuptaNational Cancer Institute
Active IndicationsN/A
Inactive Indications +[9]
Other Information
ATC CodeN/A
Related LinksN/A